Zalevsky Jonathan bought NKTR
December 22, 2025 · Form 4 insider transaction
Zalevsky Jonathan bought 6,250 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
$0.00
Total value
N/A
InsiderZalevsky Jonathan
RoleOfficer
CompanyNektar Therapeutics (NKTR)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after25,221
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substantially equal quarterly installments based on continued service.